Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Protective Role of Silymarin and Deferoxamine Against Iron Dextran-Induced Renal Iron Deposition in Male Rats



Nematbakhsh M1, 2, 3 ; Pezeshki Z1 ; Moaeidi BA4 ; Eshraghijazi F1 ; Talebi A1, 5 ; Nasri H1, 3, 6 ; Baradaran S1 ; Gharagozloo M4 ; Safari T1, 2 ; Haghighi M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Water and Electrolytes Research CenterIsfahan, Isfahan University of Medical Sciences, Iran
  2. 2. Department of Physiology, Isfahan University of Medical Sciences, Iran
  3. 3. Kidney Diseases Research Center, Isfahan University of Medical Sciences, Iran
  4. 4. Departments of Immunology, Isfahan University of Medical Sciences, Iran
  5. 5. Clinical Pathology, Isfahan University of Medical Sciences, Iran
  6. 6. Internal Medicine, Isfahan University of Medical Sciences, Iran

Source: International Journal of Preventive Medicine Published:2013

Abstract

Background: Kidney iron deposition (KID) is caused by iron overload that is observed in kidney diseases and anemia. The protective effects of deferoxamine (DF) and silymarin (SM) were studied against iron overload-induced KID in rat model. Methods: Rats received iron dextran (200 mg/kg) for a period of 4 weeks every other day, but at the beginning of week 3, they also were subjected to a 2-week (every other day) treatment with vehicle (group 2, positive control), SM (200 mg/kg; group 3), DF (50 mg/kg; group 4), SM (400 mg/kg; group 5), and combination of SM and DF (200 and 50 mg/kg, respectively; group 6). Group 1, as the negative control, received saline alone during the study. The levels of serum creatinine (Cr), blood urea nitrogen (BUN), iron, ferritin, and nitrite were determined, and the kidney was removed for histopathological investigations. Results: Before treatment, the serum levels of iron and ferritin in all iron dextran receiver groups were significantly higher than those of the negative control group (P < 0.05). However, the serum levels of BUN, Cr, and nitrite were not different between the groups. No statistical differences were detected in kidney weight and the serum levels of BUN, Cr, iron, ferritin, and nitrite after 2 weeks of treatment with SM, DF, or combination of both. The SM and DF treatments reduced the intensity of the KID, but only in the SM (200 mg/kg) group, a significant reduction in KID was observed (P < 0.05). Conclusion: It seems that SM is a nephroprotectant agent against KID in acute iron overload animal models.
Other Related Docs
28. Lowering Effect of Valsartan on Fetuin-A in Type 1 Diabetes Mellitus, Iranian Journal of Kidney Diseases (2013)
40. Astaxanthin Prevents Nephrotoxicity Through Nrf2/Ho-1 Pathway, Canadian Journal of Physiology and Pharmacology (2024)
41. Evaluation of Iron Status by Serum Ferritin Level in Iranian Carriers of Beta Thalassemia Minor, International Journal for Vitamin and Nutrition Research (2008)
47. Fractional Excretion of Magnesium (Femg), a Marker for Tubular Dysfunction in Children With Clinically Recovered Ischemic Acute Tubular Necrosis., Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia (2011)